![Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis](https://www.frontiersin.org/files/Articles/717999/fpsyt-12-717999-HTML/image_m/fpsyt-12-717999-t003.jpg)
Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
![The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder - ScienceDirect The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165178119313629-gr1.jpg)
The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder - ScienceDirect
![Management of Patients With Obsessive-Compulsive Disorder: Focus on Pharmacotherapy | Psychiatric Annals Management of Patients With Obsessive-Compulsive Disorder: Focus on Pharmacotherapy | Psychiatric Annals](https://journals.healio.com/cms/asset/dc6cc24b-a4e6-4cef-8d41-b9d63768bccc/10.3928_00485713-20220315-01-table1.jpg)
Management of Patients With Obsessive-Compulsive Disorder: Focus on Pharmacotherapy | Psychiatric Annals
Missouri Society of Health-System Pharmacists - Pharmacist Continuing Education - Keeping Up with Psychiatric Disorders: Obsessive Compulsive Disorder
![PDF) Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive–compulsive disorder | Johanna Thompson-Hollands, Michael Jenike, and Darin Dougherty - Academia.edu PDF) Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive–compulsive disorder | Johanna Thompson-Hollands, Michael Jenike, and Darin Dougherty - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45874097/mini_magick20220705-1888-97vzb4.png?1657067256)
PDF) Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive–compulsive disorder | Johanna Thompson-Hollands, Michael Jenike, and Darin Dougherty - Academia.edu
![PDF] The Treatment of Obsessive-Compulsive Disorder and the Approaches to Treatment Resistance | Semantic Scholar PDF] The Treatment of Obsessive-Compulsive Disorder and the Approaches to Treatment Resistance | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a14922c4a2935448216bc22150640ec5149ccc9e/5-Table1-1.png)
PDF] The Treatment of Obsessive-Compulsive Disorder and the Approaches to Treatment Resistance | Semantic Scholar
![Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder | Molecular Psychiatry Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmp.2009.50/MediaObjects/41380_2010_Article_BFmp200950_Fig1_HTML.jpg)